Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies
Wednesday April 26, 2017 1:00 pm to 3:00 pm
Neuromuscular and Clinical Neurophysiology (EMG)
Amanda Peltier MD, MS
Availability of noninvasive autonomic testing is expanding neurologic practice in the diagnosis and management of disorders of the autonomic nervous system. Faculty will provide a clinical overview of autonomic tests, and clinical approaches to common autonomic disorders and their diagnosis.
This program complements C180: Evaluation and Management of Autonomic Disorders II, but covers independent topics.
Participants should be able to improve their ability to formulate a differential diagnosis, organize a work-up, and a treatment plan for patients with autonomic dysfunction.
Program Speakers - Tentative
1:00 PM - 1:40 PM
Autonomic Testing: Where Is the Lesion
Wolfgang Singer MD
1:40 PM - 2:10 PM
Horacio C. Kaufmann MD, FAAN
2:10 PM - 2:40 PM
Autonomic Peripheral Neuropathies
Roy L. Freeman MD
2:40 PM - 3:00 PM
Questions and Answers
Roy L. Freeman, MD
Dr. Freeman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Astellas, Aptinyx, Biogen, Daiichi-Sankyo, Lundbeck, Mundi, Novartis, Pfizer, Regenacy and Vertex. Dr. Freeman has received personal compensation in an editorial capacity for Autonomic Neuroscience - Basic and Clinical.
Horacio C. Kaufmann, MD, FAAN
Dr. Kaufmann has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Lundbeck, Theravance and Biogen. Dr. Kaufmann has received personal compensation in an editorial capacity for Clinical Autonomic Research. Dr. Kaufmann has received research support from Theravance.
Wolfgang Singer, MD
Dr. Singer has nothing to disclose.
Ready to register for the 2018 AAN Annual Meeting?